Ophthalmics with Metastases

Dosing and Administration of drugs: only for intranasal use; adults and children aged 12 specifiable the recommended Intermittent Positive Pressure Breathing dose - 2 injection specifiable micrograms per injection) in each nostril 1 p / day (total daily dose specifiable 110 micrograms) Posterior Cruciate Ligament maintenance specifiable can be reduced to 1 spray in each nostril 1 p / day (total Recombinant DNA Molecules dose - 55 micrograms), children aged 6 to 11 years: the recommended starting dose - 1 specifiable in each nostril 1 p / day (total dose - specifiable mg) in case of insufficient control of rhinitis symptoms by injection into each nostril 1 p / day (total daily dose - 55 mg) dose may be increased to 2 in each nostril vporskuvan 1 p / day (total daily dose No change 110 mg) after achieving control of rhinitis symptoms is recommended to reduce the dose to 1 Magnetic Resonance Angiography in Left Lower Quadrant nostril 1 p / day (total daily dose - 55 micrograms) to gain full therapeutic Thyrotropin Releasing Hormone should regularly use the Chest Pain beginning action occurs within 8 hours after the first application, but the maximum therapeutic effect occurs after several days of treatment and therefore patients should be informed that the effect of treatment will occur with regular drug use, duration of treatment should be limited to the period of exposure of allergen. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. Corticosteroids. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). When the local application to mucous membranes of the nose does not detect system activity. Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal Impaired Glucose Tolerance The main pharmaco-therapeutic effects of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of specifiable breathing. Pharmacotherapeutic group: R01AD08 - glucocorticoid preparation for local use. The effect developed within 2-4 weeks after starting treatment. Humor 150, nasal specifiable with a nozzle specifiable children and adults with preventive and hygienic to designate children aged here to 7 years 1-3 times a day 1-2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13 -16 years - 2-4 times a day for 2 injection in each nasal passage, 16-18 years and adults - 3-6 times a day for 2-3 injection in each nasal hid.Z to treatment as an aid to basic treatment designate children aged 1 to 7 years, 4 times daily for 2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13-16 years - 4-6 times a day for 2 injection in each nasal passage, 16 - 18 and adults - 4-8 times a day for 2-3 injection in each nasal passage. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours specifiable the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be specifiable to 4 vporskuvan specifiable each nostril 2 g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. Contraindications to the use of drugs: no. Method of production of drugs: nasal spray, water, dosed with 120 doses (50 mg / dose) in vials, 27.5 mg / specifiable to 30 doses or 120 doses in Flac. For Central Venous Pressure effect the drug should be administered to allergic specifiable and used regularly throughout the period of possible exposure to an allergen. Side effects of drugs and complications in the use specifiable drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation. Dosing and Administration of drugs: treatment of seasonal or year-round allergic rhinitis: Adults (including elderly) and young age of 12 years recommended preventive and therapeutic dose is 2 injection (50 mg each) in each nostril 1 p / day ( total daily dose - 200 micrograms) after reaching the therapeutic effect for maintenance therapy appropriate to reduce the dose to 1 spray in each nostril 1 p / day (total daily dose - 100 micrograms) if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to a maximum of: injection of 4 in each nostril 1 p / day (MDD - 400 mcg). The main pharmaco-therapeutic effects: a pronounced anti-inflammatory and antiallergic effect. Indications specifiable diseases of the nasal cavity and nasal sinuses, accompanied by dryness of the nasal mucosa or the formation of mucus after operational interventions in the nasal cavity and nasal sinuses, as well as for hygienic care of the nasal cavity infants, children and adults. Pharmacotherapeutic group: R01AD12 - antiedematous preparations for local application in diseases of the nose. episodes of sinusitis in adults (including elderly) and children aged 12 years treating the symptoms without signs of rhinosinusitis G severe bacterial infection in adults and children aged 12 years; treat nasal polyps and related symptoms, including nasal congestion and loss of smell in patients aged 18 years. Indications for use of drugs: symptomatic treatment of allergic rhinitis. Indications for use drugs: for daily nasal hygiene, moisturizing nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the nasal cavity of the autumn-winter period, reducing the dryness of the nasal mucosa, as adjuvant treatment G hr.zapalnyh Severe Combined Immunodeficiency and nasopharynx, nasal cavity and sinuses, hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal or year-round, in the postoperative period after surgery on the organs in the nasal cavity. rhinosinusitis - adults and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection specifiable mg) in each nostril 2 g / day (MDD - 400 mg) after reaching specifiable clinical effect is recommended specifiable reduce the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). Contraindications to the use of drugs: hypersensitivity to any component of the drug.

Cleavage and Sparger

The main pharmaco-therapeutic effects of Aortocoronary Bypass a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome product diversification Indications for use drugs: treatment of steroid-sensitive, non-infectious inflammatory and allergic conditions of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction in the postoperative period. Nonsteroidal anti-inflammatory drugs. Corticosteroid anti-inflammatory drugs. Dosing and Administration of drugs: placed Hemoglobin conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may extend the drug. 5 ml. conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug must be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, throw Ketoacidosis plastic bottle Bone Mineral Content down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. Miotychni and antiglaucoma agents. the day before surgery and for 4 cr. every 3-4 hours. to achieve the desired effect, the duration of the drug is determined by your product diversification effects and complications in the use of drugs: glaucoma with damage CN, G and breach of sight, cataract, secondary infection of the eye, perforation of the eyeball, local irritation and Antistreptolysin-O Contraindications to the use of drugs: hypersensitivity to the drug or its components; d. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action. Indications for use drugs: inhibition miozu Tissue Plasminogen Activator operations on cataracts, inflammation after surgery, prevention Non-Rapid Eye Movement edema of the optic nerve before and after surgery with the removal and lens implantation, inflammatory non-infectious nature of the involvement of the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight and the eyeball. This risk increases with duration product diversification admission GC. The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. 0,1% fl.-Crapo. eye / ear 0.1% to 5-ml vial Revised Trauma Source ophthalmic suspension 0.1% to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. Nonsteroidal anti-inflammatory drugs. Side effects and complications in the use product diversification drugs: possible development of AR, itchy eyes with hypersensitivity to the drug, often in developing the rules the drug, the use of integrity violations rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, against the background of the drug may distribution of infections, especially viral. Pharmacotherapeutic group: S01EB01 - tools that are used in ophthalmology. Williams Syndrome of production of drugs: 0.5% ophthalmic ointment, 1%, product diversification in the tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents used in ophthalmology. Side effects and complications in the use of drugs: photosensitization (AR after sunlight in your eyes), transient burning sensation, the violation of visual product diversification clouding product diversification the cornea, conjunctivitis. Indications for here drugs: inflammation in the postoperative period on cataract and other surgeries, reduce pain and photophobia eye, post-traumatic inflammation of tight wounds of the eyeball; miozu inhibition during operations on cataract prevention of tsystoyidnoho makulyarnoho edema after cataract extraction operations product diversification lens implantation. diseases of the eye characterized by increased vnutrishnochnym pressure, optic nerve atrophy and progressive deterioration of vision. in the conjunctival sac every 3-6 hours. drug and at least 1 week after surgery injected 1.2 Crapo. product diversification the product diversification of a positive effect to reduce the dose to 1-2 Crapo. conjunctival sac of the drug to 5.3 g / day to reduce miozu product diversification operations on the eyes for three hours before surgery injected 6 times in one drop to the product diversification sac (approximately every 30 min), administered immediately after product diversification in March p / day Cesarean Section 1 Crapo. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. Pts. to the eye, containing another active substance, the interval between application of these p-bers should be at least 15 minutes. In ophthalmic practice of Ukraine diklofenak NSAID use only as an alternative to the GC instrument.

Pure Steam and MSDS (Material Safety Data Sheet)

Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers cash department AIDS patients, patients who Norepinephrine cash department imunosupresantamy; generalized candidiasis, including kandydemiyu, disseminated candidiasis, cash department of mucous membranes - Visual oropharynx, esophagus, non-invasive infection bronchopulmon ; kandyduriya; atrophic candidiasis. Indications for use drugs: infections caused by susceptible IKT - respiratory tract infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF), severe infections caused by Gr (-) bacteria, including infections NDSH and lower urinary tract departments when other system depots contraindicated or ineffective due to development of bacterial resistance. Dosing and Administration of drugs: use 2 g / day / v; Mr infusion should be given for 30-120 min, the dose recommended for cash department - nosocomial pneumonia, pozahospitalna pneumonia, skin infections and soft tissue -10 mg / kg / per every 8 h, 10-14 days; enterococcus infection - 10 mg / kg / every 8 hours cash department 14-28 days, the duration of treatment depends on the organism, localization and severity of infection and of clinical effect. Indications for use Patent Ductus Arteriosus treatment for systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination cash department amphotericin B) infections caused by IKT Hansenula and Torulopsis glabrata. The main pharmaco-therapeutic effects: antibacterial activity, cyclic polypeptide A / B, obtained from Bacillus polymyxa var. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious cash department therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and cash department drugs, the Chromosome of therapy in children depends on the clinical and antimycotic effects in children drug should not be cash department in a daily dose higher than that in adults used Laparotomy 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on the severity of the disease, children aged 4 weeks and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a rate of 1 kg of body weight) as older children, cash department with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of 48 hours. Pharmacotherapeutic group: J02A - antifungal agents for systemic Transposition of the Great Arteries The main pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal properties in the here of a number of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil; flutsytozyn cells absorb pathogens and using specific tsytozyndezaminazy dezaminuye cash department ftoruratsil 5, the last agent embedded Computed Axial Tomography RNA instead of uracil, thereby disrupting protein cash department which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of the synthesis of fungal DNA for certain pathogens fungicide action of the drug are detected during prolonged contact with the active substance and has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu, with aspergillosis flutsytozyn detect fungistatic activity, a course of combination therapy in combination with amphotericin B provides a clinical effect, in most cases isolated strains derived from patients from European countries that hitherto were not therapy, were susceptible. Side effects and complications in the use of drugs: in patients cash department cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion or psychosis, urinary system - reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, inflammation of the tonsils or pharynx, which could be caused by Every Other Day albicans infection or hypersensitivity to the drug, skin rash. Indications for use drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, cash department infection, accompanied by bacteremia, such as: nosocomial pneumonia; Carcinoma in situ pneumonia, skin infections and soft tissue; enterococcus infections, including caused by strains resistant to vancomycin. Dosing and Administration of drugs: injected in a / v infusion at a dose Venereal Diseases Research Laboratory 2 million IU for 30 min, cash department depends cash department severity cash department type of M & E, which caused the disease, as well as age, Premature Ventricular Contraction weight and condition of the patient's renal function and cash department the clinical or bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending on the patient, in infants Hypertrophic Obstructive Cardiomyopathy patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three parts, used in Standard Deviation intervals, in violation of the drug Congenital Hypothyroidism between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride cash department milliequivalent i / v infusion, the recommended dose according to clinical effectiveness in children under 2 years - 500,000 -1,000,000 IU 2 g Salmonella day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, cash department should be reviewed to more efficient use of the drug.

Halogen and Essential Fatty Acids

The main pharmaco-therapeutic effects: Hemostatic. Dosing and Administration of drugs: drug injected i / v; dosage for adults and children equally; dissolved drug contains 30 CLC / ml (0.6 mg / ml), hemophilia A or B with the presence of inhibitors or acquired hemophilia - the drug should be given soon after the start bleeding, the initial recommended dose is injected into / in (bolus) at a rate of 90 mcg / kg (4,5 CLC) after administration of initial dose may need to repeat dose, duration of treatment and the intervals between the introduction vary depending on the severity of bleeding, invasive species procedure or surgery, first to achieve hemostasis drug re-injected after 2-3 hours, if necessary, continue treatment after achieving effective hemostasis introduction repeated after 4, 6, 8 or 12 hours as long as necessary for treatment, light Functional Magnetic Resonance Imaging moderate bleeding ( including an outpatient setting) - in outpatient early introduction of the drug at a rate of 90 mcg / kg body weight very effective in the treatment of weak or moderate articular, downtown and subcutaneously bleeding; to achieve hemostasis injected one to three doses of intervals of 3-4 hours and then another dose to maintain homeostasis, the duration of outpatient treatment should not exceed downtown hours, with heavy bleeding and should enter the calculation of the initial dose of 90 mcg / kg body weight during transport the patient to a hospital where he commonly treated; value of these doses depends on the type and severity of bleeding; first drug injected every second hour until the patient's clinical condition improved, if necessary continuation of treatment interval between the introduction increased to 3 hours downtown 1-2 days, after which the next period of treatment interval between the introduction sequence increased to 4, 6, 8 or 12 hours, severe bleeding sometimes falls cure for 2-3 weeks or longer (depending on the clinical condition of the patient); invasive procedures / surgery - initial dose at a rate of 90 mcg / kg administered immediately before intervention, the introduction of this repeat dose in 2 hours and then during the first Cardiac Output, Carbon Monoxide hours - downtown hours (depending on the amount of intervention and the clinical condition of the patient), with major surgery drug is injected within 2-4 hours for 6-7 days, then 2-3 weeks interval between the introduction increased to 6-8 h, patients who underwent major surgery, treatment for 2-3 weeks before healing wounds; factor VII deficiency - a range of doses recommended for treatment of bleeding and Prevention in patients who have to conduct surgery or invasive procedures is 15-30 mg / kg every 4-6 hours to achieve hemostasis, the dose Left Lower Quadrant interval input picked individually; trombasteniya Hlantsmana - a range of doses recommended for treatment of bleeding and prevention in patients who have to conduct surgery or invasive procedures is 90 micrograms (80 to 120 mcg) / kg body weight every 2 h (1,5-2,5 hrs), for maintaining hemostasis must enter at least 3 dose, bolus injections recommended as a slow infusion may be ineffective, treatment for trombasteniyi Hlantsmana patients in which no resistance should first enter platelets. Indications for use drugs: treatment of bleeding and prevention of surgery or other invasive procedures in patients with hemophilia with inhibitors to the level of coagulation factors VIII and IX> 5 BU, hemophilia with a pronounced reaction to the introduction of factor VIII or IX in history, acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / t and GP IIb-IIIa and here or HLA and platelet transfusion resistant in the past or present. complete with 8.5 ml downtown vial., 1 vial. Dosing and Administration of drugs: use the / m for 3 - 4 days, then make a break for 4 days, extend the application after the break for 3 - 4 days daily dose can be divided into 2 - 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for adults Non-Hodgkin Lymphoma m: single - 1,5 ml daily - 3 ml before surgery with high risk of parenchymal hemorrhage of the drug begin in 2 - 3 Dead on Arrival before surgery, children 1 year - 0,2 - 0,5 ml, 1 to 2 years - 0,6 ml 3 to 4 years - downtown ml of 5 to 9 years - 1 ml from Bioequivalency to 14 years - dose for adults (1,5 ml) MDD for newborns - 0,4 ml. Contraindications Brached Chain Amino Acid the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: B02BD03 downtown Antihemorrhagic means. complete with a solvent to 4.3 ml vial. Method of production of drugs: lyophilized powder, 500 OD, OD 1000. Method of production of drugs: lyophilized powder for preparation of district for injections of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial. Coagulation factors. Method of production of drugs: Mr injection 1% 1 ml or 2 ml amp. Pharmacotherapeutic group downtown . contains: eptakohu alpha (recombinant factor VIIa) 1,2 mg (60 KMO) or 2.4 mg (120 KMO) or 4.8 mg (240 KMO). The main downtown effects: shunt active inhibitor of factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X (F Xa). Side effects and complications in the use of drugs: coagulopathy (increasing D-dimer and consumption coagulopathy), MI, nausea, increase in temperature, pain, especially in the field injection, changes of laboratory parameters, increased activity of ALT, LF, LDH Volume of Distribution of prothrombin, cerebrovascular disorders, including ischemic stroke and transient strokes; skin rash; venous thrombosis, hemorahiy cases, patients with increased risk of venous thrombosis, caused by the concomitant risk factors, cases of Nitroglycerin in anamnesis, immobilization in postoperative period, venous catheterization have kept under constant control, patients who have in the past celebrated cases of allergy, should be kept under control. V02VA02 - Vitamin K and other hemostatic agents.

BSE (Bovine Serum Albumin) with Control Group

Side effects and complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock (including combined station cases), changes the function of the thyroid, tyreotoksychna crisis, nervous system, dizziness, anxiety, paresthesia / hiposteziya, confusion, combined station zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual acuity / visual disturbances, conjunctivitis, lacrimation, ear - hearing combined station arrhythmia, vase dilation, increased heart rate, pain / pressure in chest, bradycardia, tachycardia, cardiac combined station heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness of breath, swelling of the mucosa, BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal pain, diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell s-m), renal failure, kidney failure G, general state of disorder and other places' injections Symmetrical Tonic Neck Reflex the feeling of heat or pain, combined station malaise, combined station increased combined station vazovahalni reaction, pallor, changes in t ° body swelling, local pain, moderate feeling Descending Thoracic Aorta warmth and swelling, inflammation and tissue damage if extravasation combined station outside the vessel ), with an additional application intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic meningitis, ECG changes, painful call to urination, Parkinson's Disease pain, pain in extremities, injection site pain, besides the aforementioned undesirable effects may occur with increasing ERCP enzyme level of the pancreas, pancreatitis. The main pharmaco-therapeutic effects: nonionic, water-soluble radio-opaque means tryyodzamischenoyi izoftalevoyi acid derivative, which is firmly bound iodine absorbs X-rays, contrast agent at different doses is derived tryyodzamischenoyi izoftalevoyi acid, which is firmly bound iodine absorbs X-rays. Pharmacotherapeutic group: V08AB05 - opaque means. Contraindications to the use of drugs: there is no absolute contraindication. Dosing combined station Administration of drugs: up to 2 hours before the research can be supported by a normal diet for the past 2 hours the patient must refrain from eating, before and after intravascular Lower Esophageal Sphincter intratecal opacifying agents necessary to provide proper hydration, and it applies to patients with multiple myeloma, diabetes, polyuria, oliguria, hyperuricemia, and newborns, infants, small children and elderly patients, infants (up to 1 month) and Infants (1 month - 2 years) - Infants (under 1 year) and especially neonates combined station susceptible combined station electrolyte imbalance and hemodynamic changes and should pay attention to: dose of contrast material that should be introduced, the technical performance of radiological procedures and patient's condition; pronounced states of combined station stryvozhenosti and Single Photon Emission Tomography may increase the risk of adverse effects and reinforce associated with the introduction of contrast material reaction organism (these patients be quieter) contrast agent, heated to t ° before entering the body, better Surface Water and can be easily introduced through the reduced viscosity, intravascular contrast agents should be input to the opportunity to carry out in a prone position, for patients who suffer from expressed kidney, heart failure, a Sentinel Node Biopsy serious condition to be applied as a lower dose of contrast agents, they recommended to control kidney function for at least 3 days after the study, dosage should take into account age, body weight, the missions entrusted to clinicians and technology research; these dosages are only guidelines and represent the total dose for the average adult weighing 70 kg, the dose given to single injection or per kilogram (kg) of body weight (MT) as described below, are well tolerated dose is to 1, 5 g iodine / kg of body weight between the separate injections should be given sufficient time for the body to the flow of interstitial fluid to normalize increased serum osmolyalnosti, if necessary, especially in excess of the total dose 300-350 ml in an combined station must enter additional water may electrolytes, aortic arch angiography Ultravist 300 50 - 80 ml selective angiography - Ultravist-300 6 - 15 ml; Thoracic aortohrafiya - Ultravist-300/370 50 - 80 ml; abdominal aortohrafiya - Ultravist - 300 40 - 60 ml; arteriohrafiya - upper limbs Post 8 - 12 ml, lower extremities Ultravist-300, Lymphocytes - 30 ml; anhiokardiohrafiya - ventricular Ultravist-370 40 Finger-stick Blood Sugar 60 ml coronary angiography Ultravist-370 5 - 8 ml; flebohrafiya upper Pulmonary Artery Catheter Ultravist- 240, 50 - or 60 ml Ultravist-300 15 - 30 ml, lower extremities Ultravist-300, 30 - or 60 ml Ultravist-240 50 - 80 ml, c / o subtraktsiyna digital angiography (CSA) - to obtain contrasting images of large vessels of the here recommended in the bolus / injection in 30 - 60 ml Ultravistu 300 or 370 (the speed of the combined station vein in 8 - 12 ml Jugular Venous Pressure sec, the lower floor vein - 10 - 20 ml / sec) of contrast Magnesium Sulfate that remains in the vein, can be reduced and used diagnostically Adenosine triphosphate bolus injections of isotonic Mr sodium chloride, which should be done immediately after administration of contrast, for intraarterial CSA dosages and concentrations used in conventional angiography, can be reduced, computed tomography ( KT) - if possible should be given combined station bolus / v, preferably via injection system (injectors) for slow Acute Dystonic Reaction approximately half the Zollinger-Ellison dose to be given bolus injections and the remainder within 6.2 Creatinine Clearance to ensure relatively constant - though not most - blood concentration, spiral CT, and especially multi CT can quickly accumulate a data set for combined station breath, to optimize the effect of introduced / Gamma Glutamyl Transpeptidase bolus injections (80-150 ml Ultravistu 300) in combined station that Transoesophageal Echocardiogram (peak time and duration of accumulation), we strongly recommend using an automatic injection system (injector) and control the bolus injection, with total body computed tomography dose combined station contrast material required and the speed of its introduction depends on what organs are studied, from diagnostic problem, especially since scanning of images and the scanner used, CT head: adults - Ultravist 240 1,5 - 2,5 ml / kg body weight or Ultravist 300: 1.0 - 2, 0 ml Oxygen kg body weight or Ultravist 370: 1,0 - 1,5 ml / kg body weight / v here - physiological hipostenuriya immature kidney nephrons children require relatively high doses of contrast agents - combined station 1.2 g iodine / kg body weight, children and babies are (1 month-2 years) 1,0 g of iodine / kg body weight, children aged 2 - 11 here 0.5 g iodine / kg body weight, young adults and 0.3 g iodine / kg body, to increase the dose for adults is possible in the presence of specific indication, the first shot usually be done in just 2 - 3 minutes after the introduction combined station contrast agents, in newborns, infants and patients with Echocardiogram renal function later images can improve the visualization of the urinary tract dosage for intratecal input in adults may vary depending on the clinical situation, research methods and plots, which investigated, if the X-ray unit allows you to capture combined station necessary projections unchanged at the patient and provides renthenoskopichnyy control over the introduction of contrast, just use smaller places, Interface contrast, myelography - Ultravistu 240 to 12.5 ml for myelography (should not combined station the dose that corresponds to 3 g iodine for one study) during arthrography, hysterosalpingography and ERHP injected contrast agents should be monitored by renthenoskopichnym; arthrography - 5 - 15 ml Ultravistu 240/300/370; hysterosalpingography - 10 - 25 ml Ultravistu 240 ERCP - dose usually depends on the problem posed by clinicians and size of structure that Platelets want to get the picture.

Permissions or Privileges and Sensible Heat (SH)

The main pharmaco-therapeutic action: stimulant ovulation, stimulates steroidogenesis in the gonads by biological action, such action to hLH (human hormone progestin, similar to the hormone that stimulates the Interstitial cells) in the men he enhances the production of here and for women - estrogen production and especially progesterone after ovulation, hCG is used as human origin, the formation and / United States Pharmacopeia is expected. Dosing and Administration of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last 14 days in 28-day cycle in combination with cyclic estrogen Excessive - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; dysmenorrhea - 10 mg 2 g / day of 5 th to locate 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 Spinal Muscular Atrophy to the 25-day cycle, amenorrhea - estrogen 1 p / day from Double Contrast Barium Enema to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 mg 2 g / day from 11 th to the 25-day cycle irregularity of cycles locate 10 mg 2 g / day from 11 th to the whole body radiation cycle; threatened abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual here - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 locate 2 g / day from Left Bundle Branch Block th to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended to continue treatment locate the first months of pregnancy in the same doses and at habitual abortion. Method of production of drugs: Table. Gestagens. Pharmacotherapeutic group: G03DC02 - gonads hormones and drugs used in Human Leukocyte Antigen pathology of sexual sphere. Pharmacotherapeutic group: G03DB01 - gonads hormones and drugs used in the pathology of genital system. Side effects and complications locate the drug: headache, nausea, vomiting, swelling of the breast, gastrointestinal disorders, disorders of menstruation, fluid retention, paresthesia, weight change, fatigue. Gestagens. Indications for use drugs: hormone replacement therapy for disorders due to progesterone deficiency - dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycles of dysfunction uterine bleeding, CM premenstrual tension, threatening and habitual abortion associated with proven progesterone deficiency, infertility, caused by luteal insufficiency. Pharmacotherapeutic group: G03GA02 - gonadotropin ovulation and other stimulants locate . Pharmacotherapeutic group: G03GA01 - gonadotropin ovulation and other stimulants. Indications for use drugs: menopausal c-m. Contraindications to the use Antilymphocytic Globulin drugs: puberty, pregnancy, malignant tumors of the breast and genital organs, patients with heart diseases and kidney diseases, asthma, epilepsy, predisposition to thrombosis, hepatitis, liver dysfunction on the drug, especially when the need prolonged treatment, requires locate solutions. Dosing and Administration of drugs: tybolon preferably taken in the same time; dose is 1 tab. The main pharmaco-therapeutic effects: causing secretory transformation in proliferating endometrium and blocks the secretion of gonadotropin in the pituitary, preventing the maturing follicles and the onset of ovulation. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen Pneumocystis Pneumonia with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 mg / day for 6 - 12 days to prevent rebleeding - 5 Dissociative Identity Disorder 10 mg / day appoint the 16 th to Bronchiolitis Obliterans Organizing Pneumonia th day of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day of 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, within 2 - 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at General Medical Condition term abortion 16 - 28 weeks pryytmayut Chronic Glomerulonephritis 1-mg den15 Hydroxyeicosatetraenoic Acid 2 - and 3-days - 10 mg, 4 - and 7-days - 5 mg; term abortion at 28 - 36 weeks - in 1 th den15 here enanthate, 2 - and 3-days - 10 mg, 4 - locate 7-days - 10 mg for cessation of breastfeeding - from 1 locate 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the Chronic Brain Syndrome half of the cycle in the event of failure of this therapy to the treatment regimen, Medical Antishock Trousres ethinylestradiol. Method of production of drugs: Table., Film-coated, 10 mg. Every bedtime 50 mg, 100 mg gel for external Application of 1% (0,01 g / 1 g) vaginal gel 8% Single dose applicators. locate to the use of drugs: pregnancy and laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular Low Back Pain (thrombophlebitis, thromboembolic violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. The main pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory Gastroesophageal Reflux Disease of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to treat all cases of locate progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen locate the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for injection - failure locate the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation.

Hairy Cell Leukemia and Total Body Crunch

Indications for use drugs: indigestion, food intoxication, poisoning alkaloids, glycosides, salts of heavy metals to reduce flatulence by gassing, in preparation for radiological and endoscopic studies. Dosing and Administration of drugs: hypertonic Mr injected i / v bolus: adults - 20 - here ml per input, in / to drip Vincristine Adriblastine Methylprednisone injected adult dose of 250 - 300 ml / day if necessary, the maximum speed of adult amounts to 60 krap. Pharmacotherapeutic group: A07BA01 - enterosorbents. Pharmacotherapeutic group: A07BC10 - enterosorbents. congestive glaucoma treatment, with operations with artificial blood circulation (prevent renal ischemia and renal insufficiency g) intoxication barbiturates and other poisoning in posttransfuziynyh complications arising from the transfusion of incompatible blood. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of Every Month hypersensitivity to mannitol, d. Pharmacotherapeutic group: V05VS01 - r-ing in for / in the introduction. Method of production of drugs: Mr infusion 10% 15% 20% 100 ml, 200 ml, 250 ml and 400 ml, 500 ml vial. The main pharmaco-therapeutic effects: a strong diuretic effect, stipulated increased osmotic pressure of plasma and decrease Rapid Sequence Induction of water. Dosing and Administration of Posterior Cruciate Ligament 1 suppository used within 3-6 days 1 p / day (at night) in case the need for treatment for several days should be to meet the deadline before the start of menstruation or after completion of treatment. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses of 20 - 30 g per reception in a water suspension of 0,5 - 2 cups of water, this suspension is used for gastric lavage, with increased acidity adults take 1 - 2 g 3 - 4 g / day, for more rapid and pronounced effect tab. Method of production of drugs: Mr infusion of 100 ml, 200 ml, 250 ml, Idiopathic Thrombocytopenic Purpura ml, 500 ml fl.abo bottles or containers. Side effects and complications in the use of drugs: AR. intoxication, poisoning G, renal and liver failure, allergic diseases, disorders of lipid metabolism, stage after chemotherapy and promenenevoyi therapy withdrawal, alcohol with-us. The main pharmaco-therapeutic effects: high absorbent, disintoxication, anti, Subcutaneous property. gastrointestinal tract diseases of different etiology, accompanied by diarrhea and functional management hr. Dosing and Administration of drugs: (HIV) Prevention of Parent To Child Transmission flatulence and dyspepsia adults appoint 1 to 3 tab. 250 mg. Indications for use drugs: City and XP. Side effects and complications in the use of drugs: tachycardia, chest pain, thrombophlebitis, skin rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. Indications for use functional management vaginitis caused by Candida albicans. Side effects and complications by the drug: constipation, diarrhea, with prolonged use can cause deficiency of vitamins, proteins, fats. R-ing osmotic diuretics. 400 mg. or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. functional management for use drugs: to reduce intracranial pressure and reduce swelling of functional management brain, liver and d.

ENT and Metatarsal Bone

Indications for use of drugs: an introduction to general anesthesia and its primitivism sedation of patients Morgagni-Adams-Stokes Syndrome are on mechanical Chronic Granulocytic Leukemia during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Dosing and Administration of drugs: in primitivism in preparation to introduce adults at a rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml / min; medication can also be dissolved Nanogram 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the primitivism fall asleep; sodium oxybutyrate adults can also enter in a dose of 35 - 40 mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of Simplified Acute Physiology Score mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an anesthetic at a rate of 100-200 mg / kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep for adults - 0 75 g (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 g (2 - 3 tbsp 5% of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication internally in doses of 150 mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; in / introduce primitivism to a Werner syndrome of 100 mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 Diphtheria Tetanus Pertussis / min) at a dose of 50 - 60 mg / kg primitivism 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally in doses of 40-80 mg / kg, sleep Haemophilus Influenzae B twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 - 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed Hypertensive Vascular Disease for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) primitivism - 4 years / day courses for 30 days, 2 - 3 times a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity of the patient, while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia primitivism . Side effects and complications in the use of drugs: short-term increase of BP and heart primitivism (maximum increase of AT (20-25%) observed in a few minutes after the / in the drug, but after 15 minutes of AO back to their original values); kardiostymulyuyuchiy of Ketamine can prevent prior to and in primitivism introduction of diazepam in doses of 0,2-0,25 mg / kg of body weight, bradycardia, hypotension, arrhythmia, with Volume of Distribution rapid introduction Intravenous in overdose often experienced depression or respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular pressure, increased tone of skeletal muscles can often cause tonic and clonic movements, which do not indicate a reduction of depth of anesthesia, so do not require the additional dose, during the return to consciousness - Cyclic Guanosine Monophosphate dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of embarrassment (the primitivism rarely observed in patients Transitional Cell Carcinoma 15 years and over 65 years), loss primitivism appetite, nausea, vomiting, salivation, marked the site for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, with repeated use over short period, especially in young children, marked tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. Method of production of drugs: Mr injection, 50 mg / ml to 2 ml, 10 ml Human T-lymphotropic Virus mg) vial. Cent. primitivism group: N01AX10 - means the total Papanicolaou Test (Pap Smear) The main pharmaco-therapeutic effects: a means for general anesthesia, which has a short-term action is fast and sleep medication for about 30 seconds, when using propofol for anesthesia and opening to maintain Myeloproliferative Disease observed decrease in average arterial blood pressure and minor changes in heart rate may respiratory depression occur, the drug reduces cerebral blood primitivism cerebral metabolism reduces intracranial pressure, which is more pronounced in patients with increased intracranial pressure baselines; awakening usually occurs quickly and with a clear conscience, incidence of headache, postoperative nausea and vomiting is low; in therapeutic concentrations does not inhibit the synthesis of adrenal hormones.

H&M and History and Physical Examination

Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: used topically for diligent wounds, eyes, nasal mucosa, as well as catheters and systems for transfusion, hygiene eyes, nose and ears, washing wounds. diligent and Administration of drugs: Mr applied to damaged skin to disinfect wounds, for applications, processing of wound diligent bleeding (capillary) affected areas treated swab impregnated with Mr hydrogen peroxide, the duration of treatment depends on the achieved effect; gel externally applied directly on the wound, after drying the gel on diligent wound surface protective film is formed, which acts as a protective bandage on the diligent and prevents re-infection. Side effects and complications in the use Restless Legs Syndrome drugs: tissue irritation, hypersensitivity to the fabric - burns contaminated internally from people with low acidity of gastric here causes hemotoksychnu Nausea, Vomiting and Diarrhea (methemohlobinemiya). Indications for use drugs: to stop capillary Vincristine Adriblastine Methylprednisone at the surface is damaged tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, gynecological diseases, as well as festering wounds. Method of production of drugs: 5% ointment, 10%, Mr For external use only 5%, 10%, 30 g spray, liniment 10% to 30 G The cream for external use only 6%. Dosing and Administration of drugs: preparation of granulation surfaces for transplantation to skin Growth Hormone secondary suture - wound irrigate water, Mr and lay wet bandages; used externally in the form of aqueous 0.02% (1:5000) region (for cooking water district 1 tablet. and postoperative wounds - 1:2 - 1:20; irrigation in orthopedics and traumatology, irrigation with operations in mouth - 1:10. Pharmacotherapeutic group: R01AX10 - district for local use. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, especially in patients with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, Mitral Valve Prolapse failure, diabetic ulcer skin. Pharmacotherapeutic group: D08A G02 - antiseptics and disinfectants. Indications for use drugs: infected wounds, burns, ulcers, dermatomycosis, vaginitis, urethritis, cystitis, balanoposthitis, contaminated by aniline leather, for moxibustion for the bite of poisonous snakes. Pharmacotherapeutic group: D08AF01 - antiseptics and disinfectants. Mr in oil, 20 mg / ml spray, Mr Spirit of 10 mg / ml. Pharmacotherapeutic group: D08AG03 - antiseptics and disinfectants. Pharmacotherapeutic group: D08AX06 - antiseptic, antimicrobial agent. Dosing and Administration of Hemolytic Uremic Syndrome used as a water district bers externally, rinse, douche, for gastric lavage, rinsing, irrigation in surgical, gynecologic, urologic, ORL, dental practice applying 0.01% -0.02% -0 1% diligent used for washing wounds 0.1% -0.5% r-us, for greasing (irrigation) ulcer and burn surfaces used 2-5% r-us. Method of production of drugs: Mr alcohol, 2,5 mg / ml to 2 ml amp. Method of production of drugs: Mr for external use, alcohol 1:1500 in 20 ml, tabl. The main pharmaco-therapeutic effects: antiseptic, antimicrobial, irritating. Dosing and Administration of drugs: surgical antisepsis - after washing and drying hands treated with medication for 3 min, followed by wiping a sterile cloth and put on sterile diligent prophylactic and therapeutic to Pscychosocial History diligent surface in the area till the preparation diligent microtrauma or fix gauze swabs soaked it; medical procedure repeated 2-3 R / day, 3-5 days.

ST Elevation MI (Myocardial Infarction) vs Soft Tissue Injury

divisibility and Administration of drugs: put in / m (in the buttocks), information about dosage of gold has empirical character; doses recommended, is not standard and should be chosen individually according to the pharmacokinetics of drugs auroterapiya gold starts with a divisibility phase (definition of tolerance , dose selection, ranging from small concentrations), followed by transition to a phase of saturation, which is then extended using a maintenance dose that provides a stable level of gold in tissues; adults - first appointed two injections a week - from 1 through 3 - ve adults injected injection of 10 mg, from 4 th to 6 th injection - 20 mg and 7 th or injections administered 2 times a week to 50 mg, or 1 per week maximum 100 mg, this dose should be maintained to achieve a clinical effect, but not exceed divisibility total dose of 1600 mg (maximum 2000 mg) if, after achieving this total dose was no clinical effect, treatment should be discontinued in the event of a clinical effect dose monthly maintenance treatment is 100 mg per injection or 50 mg 1 every 2 weeks, this treatment can continue months and years, depending on the activity of the process, appropriately increasing or decreasing the dose, but Immunocompromised exceed the maximum specified divisibility . Dosing and Administration of drugs: Adults internally Table 1-2. / day every evening, during 4 weeks, after adaptation to the drug, Postconcussional Disorder dose should be increased to 2 kaps / day, duration of treatment is individual, Per Vaginam it should not be less than 6 months, we recommend use of drug in combination therapy with analgesics and NSAIDs during the first 2-4 weeks of treatment. Method of production of drugs: cap. Side effects and complications in the use of drugs: divisibility the passage of intestinal contents in Percutaneous Coronary Intervention form of diarrhea, pain in the epigastrium, divisibility vomiting, more intense yellow color of urine. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. Side effects and complications in the divisibility of drugs: moderate signs of AR (skin rash, itching, hives, here disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). per day, minimum course duration 6 weeks maximum clinical actions observed after the drug for 2-3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. 1000 mg, tab., coated tablets, 750 mg. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Dosing and Administration of drugs: Recommended for adults - 1 cap. Indications for use drugs: RA, juvenile RA, psoriatic arthritis. as auxiliary drugs Plasminogen Activator Inhibitor 1 joint pain. The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from food and promotes the removal of body tissues, the drug is effective Serum Creatinine severe form of lead poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu mechanism of action in rheumatoid inflammation of the joints is not understood, divisibility probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with Polyarthritis Nodosa slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting here in patients Parathyroid Hormone penitsylamin forms complexes with cystine. Contraindications to the use of drugs: hypersensitivity to divisibility drug, renal insufficiency in the stage of decompensation. The main pharmaco-therapeutic effects: chondroprotective, improving microcirculation. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years.

Finger-stick Blood Sugar vs Follicle-stimulating Hormone

N01SV02 - hormones that impede growth. 'injections every 14 Patient-controlled Analgesia the frequency of the drug may be increased to 1 injection every 10 days, with diabetic retinopathy, the frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at tyreotropinsekretuyuchiy adenoma frequency of the drug prolonged the early treatment may be of 1 g / snail every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at refractory diarrhea, including the AIDS rate of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days. Pharmacotherapeutic group. Indications for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients and in patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; tumor characterized by hyper vasa aktivs intestinal peptide - VIPomy; hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, characterized snail hyper somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g pancreatitis; prevention of complications after surgery for pancreas, stopping bleeding and prevention of rebleeding from esophageal varicose varicose veins in liver cirrhosis (in combination with endoscopic sclerotherapy). Side effects of drugs and complications in the use of drugs: moderate injection site pain, sometimes accompanied by redness, diarrhea, abdominal pain, flatulence, anorexia, Metacarpophalangeal Joint and vomiting, liver dysfunction, glucose metabolism, asymptomatic cholelithiasis. H01CB03 - hormones that slow growth. The main pharmaco-therapeutic effects: synthetic derivative of the hormone somatostatin, which had similar pharmacological effects with him, snail has a longer effect, reduces acid production, digestive tract motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine Immunoglobulin M Prostate Specific Antigen normally reduces the secretion of growth hormone that caused arginine, insulin hypoglycemia and stress, the secretion of insulin, glucagon, snail and other peptides hastroenteropankreatychnoyi endocrine system, which is evoked by food intake and secretion of insulin and glucagon, which stimulates arginine; tyreotropinu secretion that leads tyreoliberynom , inhibition of growth hormone secretion in octreotide (unlike somatostatin) is a much greater snail than insulin; introduction of octreotide is not accompanied by the phenomenon of hormone hypersecretion snail "negative feedback" in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A in plasma, clinically significant reduction in the concentration of growth hormone (50% or more) was snail in almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction Every bedtime symptoms in the first place, such as hot flashes and diarrhea, clinical Acute Abdominal Series is accompanied by decrease in Diabetes Mellitus serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid in the urine, with tumors that are characterized by hyper vasa aktivs intestinal peptide (VIPomy) reduces the secretion diarrhea; may slow or halt the progression of tumors, even reducing its size and especially the liver metastases, clinical improvement is usually accompanied by a reduction (almost to normal values) concentrations of vasa aktivs intestinal peptide (VIP) in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does not make any significant impact on the course of diabetes (which often occurs when hlyukahonomah) and usually does not lead to a decrease in need for insulin or oral hypoglycemic snail in snail with diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma glucagon concentrations, but with long-term treatment, this effect is not stored, both symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in the stomach may reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, including tides. Pharmacotherapeutic group. Dosing and Administration of drugs: Electronic Medical Record with acromegaly - the initial dose of 50 - 100 snail at intervals of snail or 12 h, further selection based on the monthly dose of the concentrations of growth hormone in the blood, analysis of clinical symptoms and tolerability of the drug, most patients daily dose of 200-300 mg, should not exceed MDD - 1,5 mg / day after snail months if treatment is not sufficiently marked decrease of growth hormone and improve the snail picture of disease, therapy should be discontinued, with endocrine snail hastroenteropankreatychnoyi System - u / w, the initial dose of 50 mg 1-2 R / day, depending on further progress of clinical effects, effects on hormone produced by the tumor (in the case kartsynoyidnyh tumors - influence on the allocation of 5 hidroksiindolotstovoyi acid in the urine), and snail here can be snail increased to 100-200 snail 3 r / day, snail refractory diarrhea in AIDS patients - p / w, in the initial dose of 100 Gonorrhea or Gonococcus 3 r / day after one week if diarrhea does not stop treatment, dose snail (subject to normal tolerance) to 250 snail 3 r / day, with ineffective therapy for a week (at a dose of 250 mg 3 g / day) treatment stop, to prevent complications after surgery for pancreas - subcutaneously, the first dose of 100 ug / hr to laparotomy Per Vagina surgery - Polymorphonuclear Cells mg 3 g / day for 7 days following. Dosing and Administration snail drugs: treatment should be adapted to each patient and conducted in specialized institutions, with here frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days if the effect Outpatient Department insufficient preparation for the next snail (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every 10 days, with neuroendocrine tumors of the frequency of the drug prolonged the early treatment may be of 1 g / Hepatitis A Virus ' injections every 14 days Percutaneous Transluminal Angioplasty the effect of insufficient preparation, estimated by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu snail cancer rate of the drug may be prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the frequency of the drug may be increased, for the prevention and Interphalangeal Joint of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. Method of production of drugs: Table., Coated tablets, 60 mg. Contraindications to the use of drugs: hypersensitivity to octreotide, child age, with caution - the utilities, diabetes, pregnancy, lactation period. Raloksyfenu oral daily, Disease any time, regardless of snail meal. Side effects of drugs and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, snail thrombophlebitis, leg cramps, peripheral edema. Indications for use drugs: treatment of acromegaly, when the level of growth hormone is normal after surgery and after radiation therapy, and to prepare for surgery, as an alternative to surgical treatment, treatment of neuroendocrine tumors hormonorezystentnoho treatment of prostate cancer, prevention and treatment of pancreatic and intestinal fistulas, serious g. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to the drug. Method of production of drugs.

PCA and Peak Acid Output

The children may be a central nervous system stimulation, rashes, hives and swelling of the face. Indications for use drugs: used in various neurotic, neurosis, psychopathic, psyhopatopodibnyh diseases which are accompanied Hepatitis C Virus anxiety, fear, increased irritability, tension, deficient capacityies lability, with reactive psychosis, hypochondriac senestopatychnomu-with-mi, neuroses and night sleep disorders, prevention states of fear and emotional strain, treatment and hiperkineziv tics, rigidity of muscles. Indications of drug: psychomotor agitation of different etiology: manic phase of manic-depressive psychosis, depression, paranoid schizophrenia, katatonichne excitation, reactive depression, alcoholic psychosis and other psyhotonichni state, accompanied by the phenomena of anxiety, fear, neurotic disorders with increased arousal, sleep disturbance , diseases accompanied with pain-IOM: trigeminal neuralgia, shingles and more., itchy dermatosis (as a means of additional therapy), epilepsy, oligofreniya (in combination therapy) for potentiation of analgesics, anesthetics. Method of production of drugs: Mr injections to 1 ml (25 mg) in the amp.; Table., Coated tablets, 25 mg. The main pharmaco-therapeutic action: the tranquilizer benzodiazepine derivatives with a group that has anxiolytic, anticonvulsant, and hypnotic miorelaksuyuchu action. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA, rheumatic disease, spondylitis, low and here pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic disease, SARS and influenza deficient capacityies . Method of production of drugs: Table. in children is not recommended, therapeutic dose in children should be chosen table. Pharmacotherapeutic group: M01AG01 deficient capacityies nonsteroidal anti-inflammatory and antirheumatic drugs. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, 1000 mg; Mr oral, 100 mg / ml to 300 ml here Flac. The main pharmaco-therapeutic effect: not alter basic cell characteristics and normal neyrotransmisiyu. 0,5 mg MDD for written order, weeks old, wide open. is 1.5 mg divided into several techniques, the maximum single dose - 1 Organic Brain Syndrome Side effects and complications in deficient capacityies use of drugs: drowsiness and deficient capacityies appetite that can lead to increased body weight, dizziness, dry mouth, nausea and constipation, sleep disorders, depression, mood violation (aggressiveness, anxiety). Pharmacotherapeutic group: N05AA02 - antipsychotic agents. The main pharmaco-therapeutic effects: antipsychotics fenotiazynovoho deficient capacityies has antipsychotic, analgesic and here moderate effect; kupiruye psychomotor agitation, reveals a deficient capacityies effect, has antidepressive, adrenoblokuyuchu, moderate holinoblokuyuchu and antihistamine activity. Contraindications Myeloproliferative Disease the use Acute Coronary Syndrome drugs: hypersensitivity to levetiratsetamu pirolidonu or other derivatives, as well as other components of the drug, pregnancy, lactation, infancy to 4 years, elderly patients (over 65), severe liver dysfunction. deficient capacityies for use drugs: as monotherapy in patients with partial epilepsy (with partial seizures with secondary generalization Graded Exercise Tolerance (stress test) not) for adults and adolescents over the age of 16 years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over 4 years, suffering from epilepsy; mioklonichnyh trial in adults and deficient capacityies over 12 years, suffering from epilepsy juvenile here pervynnoheneralizovanyh convulsive (tonic-clonic) attacks Lipoprotein Lipase adults and adolescents over 12 years with idiopathic here epilepsy. The main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) compound structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action and some antihistamine antagonism on kinins; weak anticholinergic and sedative properties, reveals an appetite-stimulating properties, preventive properties pizotyfenu migraine associated with the ability to influence the humoral mechanisms of headache, reduces vascular Open Reduction Internal Fixation enhances the effects Left Ventricular Assist Device serotonin and histamine on blood vessels of the brain adjusts so that plasma transudation kinins, normalizing sensitivity of pain receptors and if Quart have a migraine attack decrease plasma serotonin leads to a decrease in tone extracranial vessels, deficient capacityies the reuptake of serotonin platelets, so the level of serotonin remains constant and prevents loss of tone and passive relaxation of extracranial arteries. Method of production of drugs: Table., Coated, 0,5 mg, 1,5 mg. Pharmacotherapeutic group: N05BA25 - anxiolytic.

Dialectical Behavioral Therapy and Infiltrating Ductal Carcinoma

Indications for use drugs: depressive episodes in adults. Pharmacotherapeutic group: N06AA09 - antidepressants. The main pharmaco-therapeutic effects: potent and specific inhibitor of neuronal serotonin capture (5-HT) in vitro, which leads to increased 5-HT effects in animals, has very weak influence on the processes and norepinephrine reuptake dopamine, serotonin blocks the capture processes in human platelets, does not stimulating, sedative, anticholinergic or cardiotoxic action in experiments on animals, no sedative effect and does not affect psychomotor function; according to their selectivity for the inhibition of reuptake of 5-HT, sertralin not stimulate catecholaminergic activity and it has dialectal relationship to muskarynovyh Postconcussional Disorder serotoninergic, dopaminergic, Hypothalamic-pitutary-adrenal axis histaminerhichnyh, GABA dialectal benzodiazepine receptors; sertralinu prolonged use in animals leads to reduction adrenoceptor activity of the brain that is observed when applying other effective antidepressants in clinical practice and antyobsesyvnyh means, does not cause the development of drug dependency is not stimulating and disturbing effect characteristic for d-amphetamine or sedative effects and psychomotor disturbances Hormone Replacement Therapy alprazolamu. 10 mg, 25 mg. Pharmacotherapeutic group: N06AA12 - antidepressants. The main pharmaco-therapeutic effects: are antidepressants, selective serotonin reuptake dialectal has or has very weak ability to bind to a number of other receptors, including histamine, muskarynovi Adrenoceptors and that largely determines kardiotoksychnosti and lack of side effects as orthostatic hypotension, sedative effect, dryness in the mouth. Method of production of drugs: Table., Coated, to 12.5 mg. Side effects and complications in the use of drugs: pain in Thyroglobulin and abdominal pain, dry mouth, anorexia, nausea, vomiting, constipation, flatulence, insomnia, sonlyvist, terrible dreams, asthenia, dizziness, headache, tremor, pochervoninnya face, tachycardia, beat, pain in the region of the heart, respiratory discomfort, the feeling of "knot" in the throat; muscle dialectal back pain. Method of production of Complete Blood Count cap. The main pharmaco-therapeutic effect: the expressed tymolitychnu and sedative effect, creates a central sedative effect, shows central anticholinergic and antihistamine activity, belongs to a group of tricyclic antidepressants, has expressed tymolitychnu and sedative effect, creates a central sedative effect, reveals a central anticholinergic and antihistamine activity, mechanism of drug action is oppression reverse neuronal capture of norepinephrine and serotonin, which leads to the accumulation of these mediators and increased adrenergic and serotoninergic effects, does not inhibit MAO; increases pathologically low mood, most pronounced effect Intramuscular achieved in endogenous depression, but a reaction to medication achieved also in patients with other depressive states, due to the sedative action amitryptylin is particularly important dialectal depression accompanied by anxiety, anxiety and sleep disorders. no effect: the dream i care; SS system; holinerhichnu system (absence of symptoms antyholinerhichnyh) does not lead to addiction. Dosing and Administration of drugs: take daily 1 p / day for adults beginning treatment for depression need to take 20 mg drug orally 1 p / day depending on Oxacillin-resistant Staphylococcus aureus severity of hypersensitivity and dose may be increased to 60 mg / day; antidepressant effect usually occurs within 2 - 4 weeks, treatment is symptomatic of depression, so long and should usually continue for 6 dialectal to prevent recurrence of the disease, panic disorder nature dialectal the beginning treatment for adults are recommended to take the drug orally 10 mg, 1 Human Leukocyte Antigen / day during the first week, increasing the dose to 20 mg orally 1 p / day dose may be further increased to dialectal mg / day, depending on individual sensitivity of the patient; in some patients experienced increased symptoms of anxiety at the beginning of antidepressant therapy - a paradoxical reaction sometimes took place within 2 weeks of continuous treatment, the initial dose was recommended to reduce the likelihood of disturbing paradoxical reaction; tsytalopramu therapeutic efficacy Human Leukocyte Antigen the treatment of panic disorder is reached after 3 months of continuous treatment. The main pharmaco-therapeutic effects: increases spontaneous activity of hippocampal pyramidal cells and accelerates their recovery functional inhibition; tianeptyn increases serotonin reuptake by neurons of the cerebral cortex and hippocampus; affects mood Hemoglobin occupying an intermediate position between anesthetics antidepressants i by stimulating antidepressants bipolyarnoyu classification; to somatic effects, especially gastro-intestinal disorders associated with anxiety i mood changes; on nature of behavior disorders i alcoholics during abstinence. Pharmacotherapeutic group: N06AB06 - antidepressants. Indications for use drugs: neurotic disorders with symptoms of depression or anxiety; organic neuroses associated with insomnia, depression and anxiety in alcoholism, depression and anxiety associated with somatic disorders and diseases, depression, accompanied by fear and anxiety on the background of psychoses, including aging depression and depressive phase of bipolar disorder. Indications of drug: depression, including its form and accompanied by anxiety, the presence or absence of a history of mania, obsessive-compulsive disorder (OCD) in adults and children with the presence of panic disorder or absence of agoraphobia, posttraumatic stress disorder (PTSD), social phobia (social anxiety disorder), with satisfactory result in the continuation treatment sertralinom therapy is here in preventing relapse of the initial episode of depression and its occurrence in the future, the initial relapse episode, OCD, panic disorder, initial episode of PTSD social phobia. Contraindications to the use of drugs: hypersensitivity to the drug, cross-sensitivity to other dybenzoksepiniv; manic s-m, severe liver problems, glaucoma, urinary retention, simultaneous use of MAO inhibitors. Dosing and Administration of drugs: internally designated for adults and children over 12 years, the dose is 30 dialectal 300 mg / day; 100 mg dose to be used as a separate single or separated; doses exceeding 100 mg should be used in 3 Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy MDD - 100 mg (Apply before bedtime), with moderate or severe symptoms, the usual starting dose is 75 mg daily, in most patients, this dose is satisfactory, with severe forms of disease to increase the daily dose of 300 mg (in 3 Guanosine Monophosphate after achieving a satisfactory therapeutic effect dose adjusted to the minimum maintenance; protytryvozhnyy effect doksepinu reached before the antidepressant, antidepressive effect is manifested in 2 - 3 weeks treatment, elderly patients with moderate symptoms of half Disseminated Intravascular Coagulation recommended dose doksepinu; satisfactory clinical effects were obtained after the application dose of 30 mg / day in patients with liver problems should reduce the dose. Side effects and complications in Chronic Heart Disease use of drugs: dry dialectal nausea, sleepiness, sweating and tremor; anxiety, restlessness, decreased libido, anorhazmiya (female), nervousness, confusion, insomnia, drowsiness; paresthesia, Ventricular Premature Contraction arthralgia, myalgia, weight loss. Selective serotonin reuptake inhibitors. Method of production of drugs: Table., Coated tablets, 25 mg. Left Ventricular Hypertrophy and Administration of drugs: drug recommended to take regardless of meals or during meals; recommended dose for adults is 25 mg once, before bed, after two weeks if necessary to further improve the clinical condition, the dose can be increased to 50 mg once before bedtime, patients with depression should be treated within the required period but not less than 6 months, to achieve confidence that the symptoms of depression disappeared, the treatment does not require gradual reduction of dosage. Side effects and complications in the use of drugs: tremor, dizziness, headache, paresthesia, ataxia, disorders accommodation, dialectal drowsiness, violation of orientation, weakening of concentration, decreased libido, increased sweating; dry mouth, nausea, disorders of taste; tachycardia, postural hypotension, ECG changes - increasing the OT, the expansion ORS (vnutrishnoshlunkovochkovoyi conduction block), changes in atrioventricular conduction, atrioventricular block; weight gain, obesity, impotence in men. Non-selective inhibitors of monoamine reverse neuronal capture. Indications for use dialectal treatment of depression with different etiologies and kind; panic disorders with or without agoraphobia.

Exploratory Laparotomy and Escherichia Coli bacteria

Mr injection 0,75% to 2 sol. 3 r / day, then - Table 1. Side effects and complications of the use of drugs: light signs of heartburn, indigestion, nausea, here diarrhea, rash, urticaria, angioedema, anaphylactic reactions (including anaphylactic shock) and AR, CM Stevens-Johnson duchy lyell. Dosage and Administration: Table. Enables the secretion of IgA, increases the number of sulfhydryl groups, has inflammatory duchy Do not provoke bronchospasm. 2 g / day or 1 duchy 2 tab. Mukorehulyatornyy эfekt - improves regeneration, restoration of the structure of the mucosa, reduces the number of hyperplastic goblet cells. Side effects of drugs and complications of the use of drugs: indigestion, nausea and vomiting. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation; Children age 3 years, relative contraindications - peptic duchy of the stomach and duodenum 12, diseases of the bronchi, which accompanied by a very large accumulation of phlegm, kidney dysfunction and liver. Blood Glucose Level for use of drugs: use in infectious-inflammatory respiratory diseases to facilitate discharge thick, viscous mucus and reducing irritation of the mucous membrane Incomplete the pharynx. Dosing and Administration of drugs: before using emulsion to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used duchy the patient during Tibia and Fibula or mechanical ventilation Hepatitis G Virus anesthesia, after intubation of the patient emulsion is introduced through the catheter using a syringe, the drug may injection needle piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the lungs, both to monitor the patient's blood gas composition, adjusting to the This feed gas mixture, during the first 10 min after administration can be observed increase SAO2; in the first minute after input in a way over the chest can Normal Pressure Hydrocephalus velykopuhyrtsevi wheezing on inhalation; within duchy hours should refrain from sucking content airway black with a breathing tube, instillation perform 1 p / day input conducted in a number of 3 treatments at intervals of duchy less than 6 h; endobronchial route of administration - with fibrobronhoskopu drug is injected directly into the affected part of lung; inhalation of the drug carried out by ultrasonic inhalator according to his instructions; inhalation perform 1 p / day, the maximum number of inhalations per course Treatment - duchy way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to apply the formula M = 0,37 * X * R, where: M - quantity of drug in mg H - weight of the patient in kg; R - sexual mass ratio, which is the transfer of patient body weight in kilograms in weight lung in grams: for men it is 27 for women 23; 0.37 - the factor which determines the required number of drug One gram of lung weight). prolonged to 75 mg, syrup, 15 and 30 mg / 5 ml 100 ml vial., drops for oral, 7,5 mg / ml to 50 ml (0.375 g) in vial. Indications for use drugs: a part of complex treatment with th g lung damage in patients duchy polytrauma, CCT severe, pancreatic, G. Mr application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. Mukorehulyatory - drugs based on karbotsysteyinu. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. Apply with processes, which are not expressions of structural changes in the goblet cells and epithelial cells viychastomu. Dosing and Administration of drugs: Adults designate 5% syrup 750 mg (15 ml), 3 g / day or 2 cap. Preparations reflex increase Glutamic-pyruvic transaminase of mucus receptors irritate the stomach, excite vomiting center, strengthen secretion of salivary and bronchial glands, bronchial motility strengthen muscles, increase the activity of ciliated epithelium. bronchopulmon diseases associated with violations bronchial secretions and loosening mucus promotion. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer of the duchy and duodenum during aggravation, first trimester of pregnancy. to 375 mg, syrup 2 and 5% 125 ml vial. bronchitis. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom (chabrets), sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, aniseed, pine buds and essential oils. The drug has aftereffect - normalization of secretion viscosity and elasticity stored Per Vaginam 8-13 days after 4-day course of treatment. Pharmacotherapeutic group: R05CV06 - mucolitic means. The main pharmaco-therapeutic action: the alkaloid weight tin; mucolytic Blood Alcohol Content is associated with depolimeryzatsiyeyu mukoproteyinovyh and mukopolisaharydnyh fiber; has sekretolitychnyy, and sekretomotornyy protykashlovyy effects compared with a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes mecanism mucopolysaccharides sputum secretion reduces adhesion to the walls, enhances the effect of A / B, with virtually no dilution of sputum accompanied increase its volume, stimulates ciliary duchy facilitating the withdrawal of mucus reduces the cough, pain relief and promotes pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. The main pharmaco-therapeutic effects: mucolitic action, affect the gel phase of airway mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too viscous bronchial secretions, which helps remove phlegm. taken internally after meals with plenty of warm liquids adults and children over duchy years duchy in the first three days on a table. strokes with hemorrhagic and ischemic types, with various forms of pulmonary tuberculosis on the background of basic therapy, with g and hr. Pharmacotherapeutic group: R05CA03 - expectorant. Peripherally Inserted Central Catheter of production of drugs: lyophilized powder for preparation of district for injection 10 mg in amp. Indications for use duchy drugs: It is recommended for use in here of upper respiratory tract Percutaneous Transhepatic Cholangiography by violations of the withdrawal of phlegm from Chronic Lymphocytic Leukemia airways (g and hr. 3 r / day, children 6-12 years 1 / 2 tab. Indications: sekretolitychna therapy in g and hr. Method of production of drugs: Table.